Direxion Daily S&P Biotech Bull 3X SharesLABU
Type
ETF
Peer group
US equity: Healthcare
Net assets
$518.9M
Expense ratio
0.93%
1-year return
+330.3%
3 years, a year
+45.0%
5 years, a year
-25.7%
12-month yield
0.35%
Holdings
161
What it aims to do.
The Fund seeks daily investment results, before fees and expenses, of 300% of the daily performance of the Index. The Fund does not seek to achieve its stated investment objective for a period of time different than a trading day.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Dreyfus Government Cash Manage | 7.90% |
| Goldman Financial | 6.66% |
| N/A | 2.78% |
| Goldman Sachs Liq Es Fd A | 1.82% |
| Apellis Pharmaceuticals Inc | 1.53% |
| N/A | 1.52% |
| RVMD Revolution Medicines Inc | 1.35% |
| TVTX Travere Therapeutics Inc | 1.33% |
| ARWR Arrowhead Pharmaceuticals Inc | 1.18% |
| TWST Twist Bioscience Corporation | 1.17% |
More on LABU.
- LABU overview
- LABU holdings
- LABU risk
- LABU costs
- LABU money in and out
- LABU share classes
- Compare LABU with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.